menu
    • menu

    Company profile for Shanghai Junshi Biosciences

    NEW Drugs in Dev: 31
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With dis...
    Junshi BioPharma is an innovation-driven biopharmaceutical company which is dedicated to the discovery and development of innovative drugs and their clinical research and commercialization on a global scale. Our mission is to provide patients with treatment options that work better and cost less. Based on the core platform technology of protein engineering, Junshi stands at the frontier of R&D of macromolecular drugs. With distinguished capability of innovative drug discovery, advanced biotechnological R&D, large-scale production capacity on the full industry chain and rapidly expanding drug candidate portfolio of tremendous market potential

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Shanghai Junshi BiosciencesChina Flag
    Country
    Country
    China
    Address
    Address
    No.780 Cailun Road, Suite 610, Zhangjiang High-Tec Park,Pudong District, Shang...
    Telephone
    Telephone
    (86)21-50796193
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://junshipharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Junshi: Phase 3 Toripalimab + Chemo Meets Endpoints in NSCLC
    Junshi: Phase 3 Toripalimab + Chemo Meets Endpoints in NSCLC

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/27/3301588/0/en/junshi-biosciences-announces-primary-endpoints-met-in-final-analysis-of-phase-3-study-for-perioperative-toripalimab-plus-chemotherapy-for-resectable-stage-ii-iii-nsclc.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Junshi Secures Toripalimab NDA for 1L HER2+ Urothelial Carcinoma
    Junshi Secures Toripalimab NDA for 1L HER2+ Urothelial Carcinoma

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299131/0/en/junshi-biosciences-announces-approval-of-toripalimab-nda-for-the-1st-line-treatment-of-her2-expressing-urothelial-carcinoma.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Junshi Presents Phase 2 BsAb and ADC Data at AACR 2026
    Junshi Presents Phase 2 BsAb and ADC Data at AACR 2026

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3277510/0/en/junshi-biosciences-presents-results-from-js207-pd-1-vegf-bsab-phase-2-combo-studies-and-js212-egfr-her3-adc-fih-phase-1-2-study-at-aacr-2026.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    Junshi Biosciences Reveals 2025 Financials And Corporate Updates
    Junshi Biosciences Reveals 2025 Financials And Corporate Updates

    13 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/13/3255597/0/en/Junshi-Biosciences-Announces-2025-Full-Year-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    13 Mar 2026
    Share Share
    Junshi NMPA Accepts Toripalimab SC NDA In 12 Indications
    Junshi NMPA Accepts Toripalimab SC NDA In 12 Indications

    09 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/09/3251876/0/en/Junshi-Biosciences-Announces-NMPA-Acceptance-of-New-Drug-Applications-for-Toripalimab-Injection-Subcutaneous-Across-12-Indications.html

    GLOBENEWSWIRE
    09 Mar 2026
    Share Share
    Junshi Accepts NDA For Roconkibart (IL-17A) for Plaque Psoriasis
    Junshi Accepts NDA For Roconkibart (IL-17A) for Plaque Psoriasis

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200830/0/en/Junshi-Biosciences-Announces-Acceptance-of-the-NDA-for-Roconkibart-IL-17A-for-the-Treatment-of-Moderate-to-Severe-Plaque-Psoriasis.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search